TOPICS·PRODUCT SAFETY & CONFORMITY

EU CE Marking Framework

The conformity assessment and marking system that gates access to the European single market -- covering 25+ directives and regulations, from low-voltage electronics to medical devices to construction products.

EUIN FORCEFramework since 1993New Legislative Framework 200835 regulations tracked
IN A NUTSHELL
WHAT
EU product conformity framework requiring manufacturers to demonstrate compliance with essential health, safety, and environmental requirements before placing products on the single market. The CE marking is the visible indicator that a product meets all applicable EU legislation.
WHO
Manufacturers, authorised representatives, importers, and distributors of products covered by CE marking directives: electronics, machinery, medical devices, toys, PPE, pressure equipment, construction products, radio equipment, and more.
WHEN
Framework operational since 1993. New Legislative Framework since 2008. Each product directive sets its own application dates. Upcoming: new Machinery Regulation (Jan 2027), Cyber Resilience Act (Dec 2027).
PENALTY
Set by Member States: market withdrawal, product recall, fines, import bans, criminal prosecution for fraudulent marking. Market Surveillance Regulation 2019/1020 coordinates cross-border enforcement.
THE ESSENTIALS

CE marking is the legal ticket that lets a product be sold in Europe. It is not a quality seal or an award -- it is a declaration by the manufacturer that the product meets all the safety, health, and environmental requirements set by the EU directives that apply to it. Without it, a product covered by those directives simply cannot be placed on the European market. That market covers over 450 million consumers across 27 Member States plus the EEA countries.

The system works like this: manufacturers figure out which EU directives apply to their product (there may be several -- a wireless gadget could fall under the Radio Equipment Directive, the Low Voltage Directive, the EMC Directive, and RoHS simultaneously). They then test and assess the product against the essential requirements of each directive, prepare technical documentation proving compliance, and sign a Declaration of Conformity taking personal legal responsibility. For lower-risk products, the manufacturer can do all of this themselves. For higher-risk products -- pressure vessels, medical devices, equipment for explosive atmospheres -- an independent third party called a notified body must be involved.

The whole framework is built on Decision 768/2008/EC, which standardises the rules across all product sectors. It defines a menu of conformity assessment procedures, called modules A through H1, ranging from simple self-certification to full quality assurance with design examination by a notified body. Each product directive specifies which modules are available, and the choice depends on the level of risk the product poses.

Getting it wrong is not a bureaucratic inconvenience -- it is a legal violation. Market surveillance authorities across the EU can pull non-compliant products off shelves, block imports at the border, impose fines, and in cases of fraudulent marking, pursue criminal charges. The system is expanding too: from December 2027, the Cyber Resilience Act will require software products to carry CE marking for the first time, bringing an entirely new category of companies into the framework.

CE marking is not a quality mark -- it is a legal prerequisite for market access. Without it, products covered by applicable EU legislation cannot be legally placed on the single market, which represents over 450 million consumers and is the world's largest regulatory bloc for product safety. The marking declares that the manufacturer has assessed the product against all applicable essential requirements and takes responsibility for its conformity.

The system is built on the New Legislative Framework (NLF), adopted in 2008, which harmonises the conformity assessment infrastructure across all product sectors. Decision 768/2008 establishes a common menu of conformity assessment modules (A through H1), standardised definitions of economic operator obligations, and a uniform approach to market surveillance. Regulation 765/2008 sets the rules for accreditation of conformity assessment bodies and market surveillance coordination.

The framework is expanding. The Cyber Resilience Act will bring pure software products into the CE marking system for the first time from December 2027. The new Machinery Regulation modernises conformity assessment for AI-enabled and autonomous machines. The General Product Safety Regulation provides a safety net for risks not addressed by specific product legislation. Each expansion adds complexity: a single product may need to comply with three, four, or more directives simultaneously, each with its own essential requirements, harmonised standards, and conformity assessment procedures.

For manufacturers, the operational implications are significant. Technical documentation must be maintained for ten years (or longer under some directives). Notified body certificates have limited validity. Harmonised standards are revised regularly. Post-market obligations require ongoing monitoring, incident reporting, and corrective action capability. The cost of getting CE marking wrong -- market withdrawal, recalls, fines, reputational damage -- far exceeds the cost of doing it right.

25+
DIRECTIVES
EU harmonisation directives and regulations requiring CE marking
450M
CONSUMERS
Single market population gated by CE marking compliance
16
MODULES
Conformity assessment modules from A (self-certification) to H1 (full QA + design exam)
10yr
RETENTION
Minimum documentation retention period after product placed on market
Apr 23, 2026
YOU ARE HERE

The CE marking framework spans these core directives. Each sets its own essential requirements and conformity assessment procedures.

REF.DIRECTIVE / REGULATIONSCOPEMODULE(S)NB
2014/35/EULow Voltage Directive (LVD)Electrical equipment 50-1000V AC / 75-1500V DCA (internal production control)--
2014/30/EUElectromagnetic Compatibility (EMC)All electrical and electronic equipmentA / B+C--
2006/42/ECMachinery DirectiveMachinery, safety components, lifting accessoriesA / various (Annex IV products require NB)Yes
2014/68/EUPressure Equipment Directive (PED)Pressure equipment and assemblies > 0.5 barA through H1 (risk-based)Yes
2014/34/EUATEX DirectiveEquipment for explosive atmospheresB+D / B+F / GYes
2014/53/EURadio Equipment Directive (RED)Radio equipment (Wi-Fi, Bluetooth, cellular, etc.)A / B+C / HYes
305/2011Construction Products Regulation (CPR)Construction products placed on the EU marketSystem 1+ / 1 / 2+ / 3 / 4Yes
2014/29/EUSimple Pressure Vessels DirectiveWelded pressure vessels for air or nitrogenA / B+C / B+DYes

Decision 768/2008 defines a standardised menu of modules. The applicable directive specifies which modules are available for each product category.

MODULE A
Design + ProductionSELF-CERTIFICATIONLOW EFFORT

Internal production control

Manufacturer self-assesses conformity. Prepares technical documentation, ensures production conformity, draws up DoC, and affixes CE marking. No notified body involvement.

TYPICAL USE

Low-risk products: consumer electronics (LVD, EMC), toys, simple electrical equipment

MANUFACTURERINVOLVED
NOTIFIED BODYNOT REQUIRED
MODULE FLOW OVERVIEW
SELF-CERTIFICATION
A -- Internal production control
A1 -- + product testing
TYPE EXAMINATION + PRODUCTION
B -- EU type-examination
↓ followed by one of:
C -- Internal control
D -- QA of production
E -- Product QA
F -- Product verification
FULL QA / UNIT
G -- Unit verification
H -- Full quality assurance
H1 -- Full QA + design exam
Self-certification Notified body required

The DoC is a legal document signed by the manufacturer, declaring that the product meets all applicable EU requirements. It must accompany the product or be available on request.

01
Manufacturer identification
Full name and registered address of the manufacturer (or authorised representative).
02
Product identification
Product name, type, batch, or serial number allowing traceability.
03
Applicable legislation
Full list of all EU directives and regulations the product complies with, including publication references.
04
Harmonised standards
References to harmonised standards applied, or other technical specifications used for conformity.
05
Notified body details
Name, number, and address of any notified body involved in the conformity assessment, plus certificate references.
06
Responsible person
Name, function, and signature of the person authorised to sign on behalf of the manufacturer.
07
Date and place
Date and place of issue. Must be updated if the product design or applicable legislation changes.
08
Additional information
Performance data, test results, or conditions of use required by specific directives.
IMPORTANT

The DoC must cover all applicable directives in a single document. Where different directives require different information, the DoC must include all required elements. The manufacturer (or authorised representative) must retain the DoC for at least 10 years after the product is placed on the market.

Notified bodies are third-party conformity assessment organisations designated by EU Member States. They are required when the applicable directive mandates independent verification.

01Designation

Notified bodies are designated by the national authority (Notifying Authority) of an EU Member State and notified to the European Commission. They are listed in the NANDO database.

02Accreditation

Typically accredited by the national accreditation body (e.g., DAkkS in Germany, UKAS in UK) under EN ISO/IEC 17065 (product certification), 17025 (testing), or 17021 (management systems).

03Type examination

Examines a representative specimen (type) of the product and assesses whether it meets the essential requirements. Issues an EU type-examination certificate (Module B).

04Production surveillance

Monitors the manufacturer's quality management system and/or conducts periodic or unannounced inspections during production (Modules D, E, H).

05Product verification

Tests and verifies every product or a statistical sample against the approved type or applicable requirements (Modules F, G).

06Certificate management

Issues, suspends, withdraws, or restricts certificates based on ongoing compliance. Must notify the Commission and other notified bodies of certificate changes.

07Impartiality

Must be independent from the manufacturer. Cannot provide consultancy to manufacturers on how to achieve compliance and then certify the same products.

Since Brexit, the UK operates a parallel conformity marking system. This comparison reflects the status as of 2026.

ASPECTCE MARKING (EU)UKCA MARKING (UK)
TerritoryEU 27 Member States, EEA (Norway, Iceland, Liechtenstein), Turkey, Switzerland (partial)Great Britain (England, Scotland, Wales). Northern Ireland uses CE marking under the Windsor Framework.
Legal basisNew Legislative Framework (Regulation 765/2008, Decision 768/2008)UK Product Safety and Metrology etc. (Amendment etc.) (EU Exit) Regulations 2019. Based on pre-Brexit EU law, separately maintained.
Conformity assessmentEU harmonised standards; conformity assessment by EU-notified bodiesUK designated standards (initially identical to EU); conformity assessment by UK-approved bodies
Notified / Approved bodiesNotified bodies designated by EU Member States and listed in the NANDO databaseUK-approved bodies designated by UKAS (UK Accreditation Service). EU notified body certificates not accepted.
Declaration of conformityEU Declaration of Conformity referencing EU directives/regulationsUK Declaration of Conformity referencing UK statutory instruments (SI equivalents of EU directives)
Marking requirementsCE marking: minimum 5mm height, proportional, visible, legible, indelibleUKCA marking: minimum 5mm height, separate symbol from CE. Both markings may appear on the same product for dual market access.
Importer obligationsEU-based importer or authorised representative required since Market Surveillance Regulation 2019/1020UK-based importer required. Product must bear the name and address of a UK economic operator.
Current status (2026)Fully operational. Continuously updated with new legislation (CRA, new Machinery Regulation).UK extended CE marking recognition indefinitely in most sectors (announced Dec 2024). UKCA marking remains available as an alternative.
Transition provisionsNo transition -- CE marking is the established EU systemUK recognises CE marking for most product categories without end date. Products can use CE, UKCA, or both.

How EU authorities enforce CE marking compliance, from documentation checks to penalties.

01
Pre-market documentation check
Market surveillance authorities may request technical files, DoC, and test reports before or after products enter the market. Customs authorities at EU borders verify CE marking presence on imported goods.
02
Risk-based inspections
Authorities prioritise inspections based on product risk profiles, complaint history, RAPEX/Safety Gate notifications, and intelligence from customs. Inspections may be physical, documentary, or a combination.
03
Product testing
Authorities may purchase products from the market (including online) and submit them to accredited laboratories for testing against applicable harmonised standards and essential requirements.
04
Non-compliance findings
If a product is found non-compliant, the authority notifies the economic operator and requires corrective action. The operator must bring the product into compliance, withdraw it from the market, or recall it.
05
RAPEX / Safety Gate notification
Serious risks trigger notification through the Safety Gate (formerly RAPEX) rapid alert system, which informs all EU Member States simultaneously. Products may be banned across the entire single market.
06
Penalties and enforcement
Member States set penalties, which may include fines, product destruction, sales bans, import prohibitions, and in cases of fraudulent CE marking, criminal prosecution.
01
Identify Applicable Legislation
Determine which EU directives and regulations apply to the product. A single product can fall under multiple directives (e.g., LVD + EMC + RoHS + RED). All applicable essential requirements must be met.
02
Apply Harmonised Standards
Use referenced harmonised standards (hENs) to demonstrate conformity. Applying hENs creates a legal presumption of conformity with the essential requirements they cover. Check the Official Journal for current references.
03
Conduct Conformity Assessment
Follow the conformity assessment module specified by the applicable directive. This ranges from self-assessment (Module A) to full quality assurance with design examination (Module H1), depending on the product risk.
04
Compile Technical Documentation
Prepare a technical file including design calculations, test reports, risk assessments, material specifications, and production quality procedures. Must be retained for at least 10 years after the last product is placed on the market.
05
Draw Up the Declaration of Conformity
The EU Declaration of Conformity is a legally binding document signed by the manufacturer. It must list all applicable directives, applied standards, notified body details (if applicable), and identify the product unambiguously.
06
Affix the CE Marking
Apply the CE marking visibly, legibly, and indelibly on the product, packaging, or accompanying document. Minimum height 5mm, maintaining correct proportions. Where a notified body is involved, its four-digit number follows the CE mark.

Select your company type for tailored compliance guidance.

KEY OBLIGATIONS
Identify all applicable EU harmonisation legislation for each product line
Conduct conformity assessment per the required module (self-assessment or via notified body)
Prepare and maintain technical documentation (design files, test reports, risk assessments)
Draw up an EU Declaration of Conformity for each product type
Affix CE marking visibly, legibly, and indelibly -- minimum 5mm height, correct proportions
Implement post-market surveillance and corrective action procedures
YOUR FIRST STEP

Map each product to all applicable CE marking directives and verify that conformity assessment procedures are complete, documented, and current.

JUR.TITLESTATUSLINKS
EURegulation (EU) 2023/988 of the European Parliament and of the Council of 10 May 2023 on general product safety, amending Regulation (EU) No 1025/2012 of the European Parliament and of the Council and Directive (EU) 2020/1828 of the European Parliament and the Council, and repealing Directive 2001/95/EC of the European Parliament and of the Council and Council Directive 87/357/EEC (Text with EEA relevance)Adopted8
EURegulation (EU) 2017/2394 of the European Parliament and of the Council of 12 December 2017 on cooperation between national authorities responsible for the enforcement of consumer protection laws and repealing Regulation (EC) No 2006/2004 (Text with EEA relevance)Adopted6
EUCommission Implementing Regulation (EU) 2025/2526 of 16 December 2025 amending Implementing Regulation (EU) 2023/2713 to correct the designation of an EU reference laboratory and to designate European Union reference laboratories for in vitro diagnostic medical devices intended for detection or quantification of markers of parasite infection and detection of blood grouping markersAdopted1
EUCommission Implementing Regulation (EU) 2025/2086 of 17 October 2025 laying down, pursuant to Regulation (EU) 2021/2282 on health technology assessment, procedural rules for the interaction during, exchange of information on, and participation in, the preparation and update of joint clinical assessments of medical devices and in vitro diagnostic medical devices at Union level, as well as templates for those joint clinical assessmentsAdopted1
EUCommission Implementing Regulation (EU) 2025/1234 of 25 June 2025 amending Implementing Regulation (EU) 2021/2226 as regards the medical devices for which the instructions for use may be provided in electronic formAdopted1
EUCommission Implementing Regulation (EU) 2025/1197 of 19 June 2025 imposing an International Procurement Instrument measure restricting the access of economic operators and medical devices originating in the People’s Republic of China to the European Union public procurement market for medical devices pursuant to Regulation (EU) 2022/1031 of the European Parliament and of the CouncilAdopted1
EUCommission Implementing Regulation (EU) 2025/117 of 24 January 2025 laying down rules for the application of Regulation (EU) 2021/2282 with regard to the procedures for joint scientific consultations on medical devices and in vitro diagnostic medical devicesAdopted1
EUCommission Implementing Regulation (EU) 2024/2958 of 29 November 2024 determining the output indicators relevant for Regulation (EU) 2023/988 of the European Parliament and of the Council on general product safetyAdopted1
EUCommission Implementing Regulation (EU) 2024/2699 of 18 October 2024 laying down, pursuant to Regulation (EU) 2021/2282 of the European Parliament and of the Council, detailed procedural rules for the cooperation of the Member State Coordination Group on Health Technology Assessment and the Commission with the European Medicines Agency in the form of exchange of information as regards the joint clinical assessment of medicinal products and medical devices and in vitro diagnostic medical devices and as regards the joint scientific consultation on medicinal products and medical devicesAdopted1
EUCommission Implementing Regulation (EU) 2023/2713 of 5 December 2023 designating European Union reference laboratories in the field of in vitro diagnostic medical devicesAdopted1
VIEW ALL →
DATEJUR.TITLESTATUS
Dec 16, 2025EUCommission Implementing Regulation (EU) 2025/2526 of 16 December 2025 amending Implementing Regulation (EU) 2023/2713 to correct the designation of an EU reference laboratory and to designate European Union reference laboratories for in vitro diagnostic medical devices intended for detection or quantification of markers of parasite infection and detection of blood grouping markersAdopted
Oct 17, 2025EUCommission Implementing Regulation (EU) 2025/2086 of 17 October 2025 laying down, pursuant to Regulation (EU) 2021/2282 on health technology assessment, procedural rules for the interaction during, exchange of information on, and participation in, the preparation and update of joint clinical assessments of medical devices and in vitro diagnostic medical devices at Union level, as well as templates for those joint clinical assessmentsAdopted
Jun 25, 2025EUCommission Implementing Regulation (EU) 2025/1234 of 25 June 2025 amending Implementing Regulation (EU) 2021/2226 as regards the medical devices for which the instructions for use may be provided in electronic formAdopted
Jun 19, 2025EUCommission Implementing Regulation (EU) 2025/1197 of 19 June 2025 imposing an International Procurement Instrument measure restricting the access of economic operators and medical devices originating in the People’s Republic of China to the European Union public procurement market for medical devices pursuant to Regulation (EU) 2022/1031 of the European Parliament and of the CouncilAdopted
Jan 24, 2025EUCommission Implementing Regulation (EU) 2025/117 of 24 January 2025 laying down rules for the application of Regulation (EU) 2021/2282 with regard to the procedures for joint scientific consultations on medical devices and in vitro diagnostic medical devicesAdopted
Nov 29, 2024EUCommission Implementing Regulation (EU) 2024/2958 of 29 November 2024 determining the output indicators relevant for Regulation (EU) 2023/988 of the European Parliament and of the Council on general product safetyAdopted
Oct 18, 2024EUCommission Implementing Regulation (EU) 2024/2699 of 18 October 2024 laying down, pursuant to Regulation (EU) 2021/2282 of the European Parliament and of the Council, detailed procedural rules for the cooperation of the Member State Coordination Group on Health Technology Assessment and the Commission with the European Medicines Agency in the form of exchange of information as regards the joint clinical assessment of medicinal products and medical devices and in vitro diagnostic medical devices and as regards the joint scientific consultation on medicinal products and medical devicesAdopted
Jun 13, 2024EURegulation (EU) 2024/1860 of the European Parliament and of the Council of 13 June 2024 amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards a gradual roll-out of Eudamed, the obligation to inform in case of interruption or discontinuation of supply, and transitional provisions for certain in vitro diagnostic medical devices (Text with EEA relevance)Adopted
Dec 5, 2023EUCommission Implementing Regulation (EU) 2023/2713 of 5 December 2023 designating European Union reference laboratories in the field of in vitro diagnostic medical devicesAdopted
Nov 13, 2023EUCommission Regulation (EU) 2023/2482 of 13 November 2023 amending Regulation (EC) No 1907/2006 of the European Parliament and of the Council as regards the substance bis(2-ethylhexyl) phthalate (DEHP) in medical devicesAdopted
Jul 27, 2023EUCorrigendum to Commission Delegated Directive (EU) 2023/1526 of 16 May 2023 amending Directive 2011/65/EU of the European Parliament and of the Council as regards an exemption for lead as a thermal stabilizer in polyvinyl chloride used as base material in sensors used in in vitro diagnostic medical devices (Official Journal of the European Union L 185 of 24 July 2023)Adopted
May 16, 2023EUCommission Delegated Directive (EU) 2023/1526 of 16 May 2023 amending Directive 2011/65/EU of the European Parliament and of the Council as regards an exemption for lead as a thermal stabilizer in polyvinyl chloride used as base material in sensors used in in vitro diagnostic medical devices (Text with EEA relevance)Adopted
May 10, 2023EURegulation (EU) 2023/988 of the European Parliament and of the Council of 10 May 2023 on general product safety, amending Regulation (EU) No 1025/2012 of the European Parliament and of the Council and Directive (EU) 2020/1828 of the European Parliament and the Council, and repealing Directive 2001/95/EC of the European Parliament and of the Council and Council Directive 87/357/EEC (Text with EEA relevance)Adopted
Mar 15, 2023EURegulation (EU) 2023/607 of the European Parliament and of the Council of 15 March 2023 amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards the transitional provisions for certain medical devices and in vitro diagnostic medical devices (Text with EEA relevance)Adopted
Dec 1, 2022EUCommission Implementing Regulation (EU) 2022/2346 of 1 December 2022 laying down common specifications for the groups of products without an intended medical purpose listed in Annex XVI to Regulation (EU) 2017/745 of the European Parliament and of the Council on medical devices (Text with EEA relevance)Adopted